13F HOLDINGS REPORT
BIOS Capital Management, LP
Quarter ended Q1 2025 · Filed May 14, 2025 · Accession 0001104659-25-048606
Total Value
$79.2M
Positions
9
Other Managers
1
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INC | ACTU | 8,509,224 | $57.6M | 72.76% |
| 2 | ACTUATE THERAPEUTICS INC | ACTU | 1,384,427 | $9.4M | 11.84% |
| 3 | LANTERN PHARMA INC | LTRN | 1,207,709 | $4.3M | 5.40% |
| 4 | REIN THERAPEUTICS INC | RNTX | 1,498,751 | $2.7M | 3.35% |
| 5 | COGNITION THERAPEUTICS INC | CGTX | 5,499,905 | $2.3M | 2.92% |
| 6 | IN8BIO INC | INAB | 8,600,001 | $1.4M | 1.80% |
| 7 | OPUS GENETICS INC | IRD | 995,249 | $977,135 | 1.23% |
| 8 | REIN THERAPEUTICS INC | RNTX | 192,000 | $339,840 | 0.43% |
| 9 | COGNITION THERAPEUTICS INC | CGTX | 500,095 | $210,440 | 0.27% |